Eur J Clin Pharmacol 79(9):123948 Mailhac A, Pedersen L, Pottegrd A, Sndergaard J, Mogensen T, Srensen HT et al (2024) Semaglutide (Ozempic) Use in Denmark 2018 through 2023 - user trends and off-label prescribing for weight loss
Combined thiazolidinedione-insulin therapy: should we be concerned about safety
2014;57(Suppl1):S389
GLP-1 also results in appetite suppression through delayed gastric emptying and induction of early satiety through interactions with receptors in the gastrointestinal tract and hypothalamus
Rather than guessing whether you need 5 mg or 15 mg, your provider can begin titration with a more informed strategy, potentially reaching your optimal dose faster and with fewer trial-and-error adjustments
Clinical Takeaways for Practice These findings support considering chronic cough as a potential adverse event signal during GLP-1 receptor agonist therapy, even when reflux is not documented